Dual GLP-1/GIP agonist tirzepatide has exhibited impressive histological benefits including both MASH resolution and fibrosis improvement rates exceeding 50% in phase 2 studies
For women who have had difficulty conceiving due to obesity, it may be important to speak with your doctor about the potential for an unexpected pregnancy if birth control has not been a part of the equation due to perceived or assumed low risk for pregnancy
Some practitioners step down from 2.4mg to 1.7mg for a month, then to 1.0mg for a month, then to 0.5mg for a month before stopping completely
Personalized weight loss treatment plan Lab tested for quality Same price for all doses
What sets Retatrutide apart is its triple agonist profile, which could mean higher efficacy at its upper dosing levels without the need for further escalation beyond 12 mg
Telegram, GMP , , (Retatrutide, LY3437943) GLP-1 ( -1), GIP ( )